ATHA
Price
$4.70
Change
-$0.00 (-0.00%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
18.52M
Intraday BUY SELL Signals
PBM
Price
$2.79
Change
+$0.24 (+9.41%)
Updated
Nov 13 closing price
Capitalization
653.64K
Intraday BUY SELL Signals
Interact to see
Advertisement

ATHA vs PBM

Header iconATHA vs PBM Comparison
Open Charts ATHA vs PBMBanner chart's image
Athira Pharma
Price$4.70
Change-$0.00 (-0.00%)
Volume$446
Capitalization18.52M
Psyence Biomedical
Price$2.79
Change+$0.24 (+9.41%)
Volume$131.47K
Capitalization653.64K
ATHA vs PBM Comparison Chart in %
ATHA
Daily Signal:
Gain/Loss:
PBM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATHA vs. PBM commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and PBM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ATHA: $4.70 vs. PBM: $2.55)
Brand notoriety: ATHA and PBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 27% vs. PBM: 5%
Market capitalization -- ATHA: $18.52M vs. PBM: $653.64K
ATHA [@Biotechnology] is valued at $18.52M. PBM’s [@Biotechnology] market capitalization is $653.64K. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, ATHA is a better buy in the long-term than PBM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 6 TA indicator(s) are bullish while PBM’s TA Score has 4 bullish TA indicator(s).

  • ATHA’s TA Score: 6 bullish, 3 bearish.
  • PBM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than PBM.

Price Growth

ATHA (@Biotechnology) experienced а +12.17% price change this week, while PBM (@Biotechnology) price change was -5.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($18.5M) has a higher market cap than PBM($654K). ATHA YTD gains are higher at: -19.891 vs. PBM (-84.837). PBM has higher annual earnings (EBITDA): -46.56M vs. ATHA (-56.92M). ATHA has less debt than PBM: ATHA (1.02M) vs PBM (2.5M). ATHA (0) and PBM (0) have equivalent revenues.
ATHAPBMATHA / PBM
Capitalization18.5M654K2,829%
EBITDA-56.92M-46.56M122%
Gain YTD-19.891-84.83723%
P/E RatioN/A0.07-
Revenue00-
Total CashN/A1.93M-
Total Debt1.02M2.5M41%
TECHNICAL ANALYSIS
Technical Analysis
ATHAPBM
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signal:
Gain/Loss:
PBM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NISN3.70N/A
N/A
NiSun International Enterprise Development Group Co Ltd
TEAM155.50-2.04
-1.29%
Atlassian Corp
SUIG2.25-0.04
-1.75%
Sui Group Holdings Limited
UP1.21-0.03
-2.42%
Wheels Up Experience
TMDX119.18-2.96
-2.42%
TransMedics Group

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+1.62%
ALNY - ATHA
35%
Loosely correlated
+0.17%
OGEN - ATHA
35%
Loosely correlated
+2.65%
ALGS - ATHA
35%
Loosely correlated
-3.37%
AURA - ATHA
35%
Loosely correlated
-1.59%
CDXS - ATHA
35%
Loosely correlated
+7.22%
More

PBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBM has been loosely correlated with NEVPF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PBM jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-4.49%
NEVPF - PBM
54%
Loosely correlated
N/A
NRSN - PBM
40%
Loosely correlated
-2.43%
IPSC - PBM
28%
Poorly correlated
N/A
ATHA - PBM
28%
Poorly correlated
+1.62%
BCRX - PBM
27%
Poorly correlated
-0.69%
More